Loading... 2 0 5 0 false
Credit Name
Damien Kee
Full Name
Kee, Damien
Loading... 3 0 5 0 false


Results 1-7 of 7 (Search time: 0.007 seconds).

Publication YearTitleAuthor(s)
129-Apr-2021Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy.Klein, Oliver ; Kee, Damien ; Markman, Ben; Carlino, Matteo S; Underhill, Craig; Palmer, Jodie ; Power, Daniel; Cebon, Jonathan S ; Behren, Andreas
212-Apr-2021Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.Klein, Oliver ; Senko, Clare ; Carlino, Matteo S; Markman, Ben; Jackett, Louise A ; Gao, Bo; Lum, Caroline; Kee, Damien ; Behren, Andreas; Palmer, Jodie ; Cebon, Jonathan S 
31-Sep-2020Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial.Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Jackett, Louise A ; Lum, Caroline; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S 
423-Jun-2020Clinical and radiological evolution of cerebral amyloid angiopathy-related inflammation in the context of anti-PD-1 immunotherapy.Lasocki, Arian; Kee, Damien 
512-Jun-2020Immunotherapy of Ipilimumab and Nivolumab in patients with advanced neuroendocrine tumours: a subgroup analysis of the CA209-538 clinical trial for rare cancers.Klein, Oliver ; Kee, Damien ; Markman, Ben; Michael, Michael; Underhill, Craig R; Carlino, Matteo S; Jackett, Louise A ; Lum, Caroline; Scott, Clare L; Nagrial, Adnan; Behren, Andreas; So, Jane Yeojeong; Palmer, Jodie ; Cebon, Jonathan S 
65-Sep-2019Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature.Gunjur, Ashray ; Klein, Oliver ; Kee, Damien ; Cebon, Jonathan S 
712-Nov-2018Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.Mitchell, Emma L; Lau, Peter Kar Han; Khoo, Chloe; Liew, David F; Leung, Jessica; Liu, Bonnia ; Rischin, Adam; Frauman, Albert G ; Kee, Damien ; Smith, Kortnye; Brady, Benjamin; Rischin, Danny; Gibson, Andrew; Mileshkin, Linda; Klein, Oliver ; Weickhardt, Andrew; Arulananda, Surein; Shackleton, Mark; McArthur, Grant; Östör, Andrew; Cebon, Jonathan S ; Solomon, Benjamin; Buchanan, Russell R C ; Wicks, Ian P; Lo, Serigne; Hicks, Rodney J; Sandhu, Shahneen